Avalo Therapeutics(DE:C6K0)
€6.98-0.51 (-6.81%)
DE:C6K0
Avalo Therapeutics earnings date
€6.98
At close:-0.51 (-6.81%)
Avalo Therapeutics (C6K0) Q4 2022 Earnings Report
0 Followers
DE:C6K0 Q4 2022 EPS Results
- Actual EPS
- -EUR 215.54
- Consensus EPS
- -EUR 159.66
- Beat/Miss
- Missed by -EUR 55.88
- One Year Ago EPS
- -EUR 418.01
DE:C6K0 Q4 2022 Revenue Results
- Actual Revenue
- EUR 812.81K
- Expected Revenue
- EUR 3.28M
- Beat/Miss
- Missed by -EUR 2.46M
- YoY Revenue Growth
- +309.13%
Earnings Announcement Details
- Quarter
- Q4 2022
- Date
- 03/29/2023
- Time
- Before Open
- Conference Call
- Wednesday, March 29, 2023
DE:C6K0 Upcoming Earnings
Avalo Therapeutics's next earnings date is estimated for March 31, 2027, based on past reporting schedules.
Q4 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:C6K0 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 31, 2027 | 2026 (Q4) | -0.41- | -0.68 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | -0.53-0.31 | -1.99 | 84.47% (+1.68) | |
| Aug 06, 2026 | 2026 (Q2) | -0.53-0.75 | -1.74 | 56.77% (+0.99) | |
| May 13, 2026 | 2026 (Q1) | -0.93-0.89 | -1.13 | 21.60% (+0.24) | |
| Mar 23, 2026 | 2025 (Q4) | -1.32-0.68 | -2.09 | 67.39% (+1.41) | |
| Nov 06, 2025 | 2025 (Q3) | -1.50-1.99 | -2.57 | 22.61% (+0.58) | |
| Aug 07, 2025 | 2025 (Q2) | -1.27-1.74 | -12.76 | 86.35% (+11.02) | |
| May 12, 2025 | 2025 (Q1) | -1.21-1.13 | -127.91 | 99.11% (+126.77) | |
| Mar 20, 2025 | 2024 (Q4) | -0.15-2.09 | -9.16 | 77.23% (+7.08) | |
| Nov 07, 2024 | 2024 (Q3) | -1.08-2.57 | -23.95 | 89.28% (+21.38) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
